Cat. #153258
Anti-CD13 [22A5] rAb
Cat. #: 153258
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 10-12 weeks
Target: Aminopeptidase N (CD13)
Class: Recombinant
Application: FACS ; IHC ; IP
Reactivity: Human
Host: Mouse
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Mike Horton
Institute: Absolute Antibody ; Queen Mary University of London
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-CD13 [22A5] rAb
- Alternate name: Alanyl Aminopeptidase; Membrane; Microsomal Aminopeptidase; Aminopeptidase M; Myeloid Plasma Membrane Glycoprotein CD13; GP15; CD13; PEPN
- Clone: 22A5
- Tool sub type: Primary antibody
- Class: Recombinant
- Conjugation: Unconjugated
- Reactivity: Human
- Host: Mouse
- Application: FACS ; IHC ; IP
- Description: Aminopeptidase N (CD13) is a cell-surface metalloprotease involved in the metabolism of regulatory peptides. 22A5 may be useful for the diagnosis and immunophenotyping of leukaemia.
- Immunogen: A cell suspension containing osteoclasts from osteoclastomas.
- Isotype: IgG2a kappa
- Recommended controls: Cells of myelomonocytic lineage
Target Details
- Target: Aminopeptidase N (CD13)
- Tissue cell line specificity: Cells of myelomonocytic lineage
- Target background: Aminopeptidase N (CD13) is a cell-surface metalloprotease involved in the metabolism of regulatory peptides. 22A5 may be useful for the diagnosis and immunophenotyping of leukaemia.
Applications
- Application: FACS ; IHC ; IP
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS
- Shipping conditions: Shipping at 4° C
References
- Original hybridoma first published in: Horton et al. 1985. Cancer Res. 45(11 Pt 2):5663-9. PMID: 4053038.
